Location History:
- Augusta, GA (US) (1988)
- Piscataway, NJ (US) (2001)
- Carmel, IN (US) (1999 - 2002)
Company Filing History:
2 out of 532 
1 out of 49 
1 out of 576 
Years Active: 1988-2002
Title: Innovations and Contributions of Jay A Tischfield
Introduction
Jay A Tischfield is a prominent inventor based in Carmel, Indiana, known for his significant contributions to the field of molecular biology. With a total of seven patents to his name, Tischfield has made remarkable advancements in understanding phospholipases and opioid receptors.
Latest Patents
Tischfield's latest patents include groundbreaking work on mammalian phospholipase A2 nucleotide sequences and low molecular weight amino acid sequences encoded thereby. His research discloses novel mammalian phospholipase (PLA) nucleotide sequences and their corresponding amino acid sequences. Specifically, he has cloned human and rat cDNAs that express different types of PLA enzymes, characterized as Type III and Type IV. These enzymes exhibit phospholipase activity and are distinguished by their unique amino acid compositions. Additionally, Tischfield has developed variant alleles of the gene encoding a mu opioid receptor, which have implications for diagnosing pain susceptibility and selecting appropriate pain relievers.
Career Highlights
Throughout his career, Tischfield has worked with various institutions, including the University of Cincinnati. His research has led to significant advancements in diagnostic methods and therapeutic approaches related to pain management and other disorders.
Collaborations
Tischfield has collaborated with notable colleagues such as Peter J Stambrook and Mary Jeanne Kreek, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Jay A Tischfield's work exemplifies the intersection of innovation and practical application in molecular biology. His patents and research continue to influence the understanding of critical biological processes and therapeutic strategies.